U.S. Securities and
Exchange Commission Washington, D.C.
20549  Form 10-Q  [x] QUARTERLY REPORT UNDER SECTION 13 OR 15
(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the quarter ended June 30, 2008   [ ]
         TRANSITION REPORT UNDER
SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the
transition period from to Commission File No.
333-123774 Immureboost, Inc. (Name of Registrant in its
Charter)  NEVADA 86-1098668 --------------- -------------------- (State or
Other Jurisdiction of (I.R.S. Employer I.D. No.) incorporation
or organization) 2764 Lake Sahara Drive, Suite 111, Las Vegas, NV 89117 (Address
of Principle Executive Offices)  Issuers
Telephone Number:  (604) 331-1459  Check whether the Issuer (1) filed all reports required
to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the Company was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. (1) Yes
  X       No (2)  Yes  X
      No  Indicate by check mark whether the
registrant is a large accelerated filer, an accelereated filer, a
non-accelerated filer, or a smaller reporting company.  See the definitions
of large accelerated filer, accelerated filer, and smaller reporting
company in Rule 12b-2 of the Exchange Act.  Large
accelerated filer [
 ] Accelerated
filer [
  ] Non-accelerated
filer [
 ] (Do not check if a smaller reporting company) Smaller
reporting company [X]   Indicate by check mark whether the registrant is a shell
company (as defined in Rule12b-2 of the Exchange Act) Yes    X     No ------
        -------  1       (APPLICABLE
ONLY TO CORPORATE ISSUERS)  State the
number of shares outstanding of each of the Issuers classes of common equity,
as of the latest practicable date: August 19, 2008:  Common Stock50,925,000
  shares DOCUMENTS
INCORPORATED BY REFERENCE  A description
of any Documents Incorporated by Reference is contained in Item 6 of this
report.    2       Immureboost, Inc. (formerly eSavingsStore.com, Inc.) TABLE OF
CONTENTS  PART I.
    FINANCIAL INFORMATION PAGE Item 1.  Financial
Statements (unaudited):  Balance Sheets 5  Statements of Operations 6   Statements of Cash Flows 7   Notes to Financial Statements
(unaudited) 8-10  Item 2.  Managements
Discussion and Analysis of Financial Condition and Results of Operation 11  Item 3.  Quantitative and
Qualitative Disclosures About Market Risk 12  Item 4T. Controls and
Procedures 16  PART II.     OTHER INFORMATION  Item 1.  Legal
Proceedings 16  Item 1A.  Risk Factors  Item 2.  Unregistered
Sales of Equity Securities and Use of Proceeds 16  Item 3.   Defaults
upon Senior Securities 16  Item 4.   Submission
of Matters to a Vote of Securities Holders 16 Item 5.   Other
Information 16 Item 6.
  Exhibits 16 Signatures 16        3    PART
I - FINANCIAL INFORMATION Item 1.   Financial
Statements  The
accompanying interim unaudited financial statements of Immureboost, Inc. (a
Nevada corporation) are condensed and, therefore, do not include all disclosures
normally required by accounting principles generally accepted in the United
States of America. These statements should be read in conjunction with the
Company's most recent annual financial statements for the year ended December
31, 2007 included in a Form10-KSB filed with the U.S. Securities and Exchange
Commission (SEC) on May 16, 2008. In the opinion of management, all
adjustments necessary for a fair presentation have been included in the
accompanying interim financial statements and consist of only normal recurring
adjustments. The results of operations presented in the accompanying interim
financial statements for the three and six months ended June 30, 2008 are not
necessarily indicative of the operating results that may be expected for the
full year ending December 31, 2008.  4


IMMUREBOOST, INC. (formerly eSAVINGSSTORE.COM,
Inc.) (A
Development Stage Company)  Unaudited Financial Statements  For
the Three and Six Months Ended June 30, 2008 and 2007, and
the Period of February 25, 2004 (date of inception) through June 30, 2008  5


IMMUREBOOST, INC. (formerly eSAVINGSSTORE.COM, Inc.) (A Development Stage Company) Balance Sheets  June 30,

December 31,2008

2007(unaudited)AssetsCurrent assets


.Cash
$
                213

$
              7,473Other receivable  (Note 6)
8,110

10,752Prepaid expense (Note 5)
-

525Total current assets
8,323

18,750Fixed assetsOffice and computer equipment
4,222

4,222Less accumulated depreciation
(4,176)

(4,152)Net fixed assets
46

70Total assets
$
              8,369

$
              18,820Liabilities and Stockholders' DeficitCurrent liabilitiesAccounts payable
$
                8,294

$
             17,603Accrued compensation  officer (Note 2)
592,873

283,830Accrued interest  notes payable (Note 7)
4,256

1,673Accrued interest  related party (Notes 2 &
7)
2,133

853Short-term loans (Note 7)
64,494

37,994Notes payable  related party (Notes 2 &
7)
32,000

32,000Note payable  timeshare, current portion (Note
7)
2,641

2,570Total current liabilities
706,691

376,523Long-term liabilitiesNote payable  timeshare, less current portion
(Note 7)
19,210

20,494Total long-term liabilities
19,210

20,494Total liabilities
725,901

397,017Stockholders' deficit (Note 4):Common stock; $.001 par value, 1,000,000,000
sharesauthorized,
50,925,000 shares issued and outstanding
50,925

50,925Additional paid-in capital
25,275

25,275Deficit accumulated during development stage
(793,732)

(454,397)Total stockholders' deficit
(717,532)

(378,197)Total liabilities and stockholders' deficit
$
            8,369

$
            18,820  See
accompanying notes to financial statements.  6    IMMUREBOOST, INC. (formerly eSAVINGSSTORE.COM, Inc.) (A Development Stage Company) Statements of Operations (unaudited)   Three Months Ended June
30,

Six Months Ended
June 30,

February 25, 2004 (inception) to
 June 30,2008

2007

2008

2007

2008(Restated  Note 10)



(Restated  Note 10)Revenues
$
            -

$
            -

$  
           -

$  
           -

$4,000ExpensesGeneral and administrative expenses
179,569

14,631

334,178

22,040

788,002Net
loss from operations
(179,569)

(14,361)

(334,178)

(22,040)

(784,002)Other Income (Expenses)Interest expense
(2,542)

(606)

(5,157)

(1,284)

(17,994)Impairment of intangible asset (Note 3)
-

-

-

-

(32,200)Gain on disposal of assets (Note 3)
-

-

-

-

40,464Total
other income (expenses)
(2,542)

(606)

(5,157)

(1,284)

(9,730)Net loss and deficit accumulated during
development stage
$(182,111)

$ (15,237)

$(339,335)

$ (23,324)

$   (793,732)Net loss per share
$      (0.00)

$      (0.00)

$       (0.00)

$     (0.00)Weighted average common shares outstanding , basic
and diluted
50,925,000

50,925,000

50,925,000

50,925,000     See accompanying notes to financial statements.  7    IMMUREBOOST, INC. (formerly eSAVINGSSTORE.COM, Inc.) (A Development Stage Company) Statements of Cash Flows (unaudited) February 25, 2004(inception) toSix Months Ended June 30,

June 30,2008

2007

2008(Restated 
Note 10)Operating
activitiesNet loss
$
         (339,335)

$
       (23,324)

$
           (793,732)Adjustments to
reconcile net loss to net cashused
in operations:Depreciation
24

78

4,176Gain
on disposal of assets
-

-

(40,464)Stock
issued for services
-

-

500Impairment
of intangible asset
-

-

32,200Changes in
operating assets and liabilities:(Increase)
decrease in other receivable
2,642

-

(8,110)Decrease
 in prepaid expense
525

-

-Increase
(decrease)  in accounts payable
(9,309)

1,383

49,658Increase
in accrued compensation  officer
309,043

-

592,873Increase
in accrued interest  notes payable
2,583

-

4,256Increase
in accrued interest  related party
1,280

-

2,133Net cash used
in operating activities
(32,547)

(21,863)

(156,510)Investing
activitiesPurchase of
fixed assets
-

-

(4,222)Net cash used
in investing activities
-

-

(4,222)Financing
activitiesIssuance of
common shares for cash
-

-

75,400Proceeds from
short-term loans
26,500

23,294

64,794Proceeds from
notes payable  related party
-

-

32,000Principal
payments on note payable
(1,213)

(1,131)

(11,249)Net cash
provided by financing activities
25,287

22,163

160,945Net increase
(decrease) in cash
(7,260)

300

213Cash at
beginning of period
7,473

-

-Cash at end of
period
$
                   213

$
                300

$
                     213Supplemental
disclosures:Interest paid
for in cash
$
                1,293

$
                678

$
                11,813Income taxes
paid for in cash
$
                       -

$
                    -

$
                         -Non-cash
investing and financing activities:Purchase of
investment property with note payable
$
                       -

$
                    -

$
                30,104Forgiveness of
debt  related party
$
                       -

$
                    -

$
                     300    See accompanying notes to financial statements.  8    IMMUREBOOST,
INC. (formerly eSAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  1. Organization and Summary of
Significant Accounting Policies This summary of
significant accounting policies of Immureboost, Inc. (formerly
eSavingsStore.com, Inc.) (a development stage company) (the Company) is
presented to assist in understanding the Company's financial statements. These
accounting policies conform to accounting principles generally accepted in the
United States of America and have been consistently applied in the preparation
of the accompanying financial statements. The Company has realized minimal
revenues from its planned principal business purpose and, accordingly, is
considered to be in its development stage in accordance with SFAS No. 7. Business
Description Immureboost, Inc. is a Nevada corporation
originally organized on February 25, 2004 to acquire timeshares and like
entities and facilitate rentals and sales of the entities and travel packages
via its full-service travel website.    On August 18, 2007, the
Company entered into an asset purchase agreement with Immureboost Inc., a
Thailand company, with the intention to purchase intellectual property to
develop products that affect the human bodys immune system.  No assets
have been acquired or stock issued to date as a result of this agreement (Note
9).  The Company has elected a fiscal year end of December 31.  On July 17, 2006, the Board of Directors
voted to change the name of the Company from Celtic Cross, Ltd., to
eSavingsStore.com, Inc. to more accurately reflect the Companys business plan.
 On July 5, 2007, the stockholders of the Company approved the name change
to Immureboost, Inc. Income Taxes The Company recognizes the tax effects of
transactions in the year in which such transactions enter into the determination
of net income, regardless of when reported for tax purposes. Deferred taxes are
provided in the financial statements under SFAS No. 109 to give effect to the
resulting temporary differences which may arise from differences in the bases of
fixed assets, depreciation methods, allowances, and start-up costs based on the
income taxes expected to be payable in future years. Development stage deferred
tax assets approximating $278,000 arising as a result of net operating loss
carryforwards totaling $793,732 have been offset completely by a valuation
allowance due to the uncertainty of their utilization in future periods.
  The valuation allowance increased by approximately $119,000 and
$8,000 during the six months ended June 30, 2008 and 2007, respectively. Estimates Preparation of financial statements in
accordance with accounting principles generally accepted in the United States of
America requires the use of estimates, such as depreciation and valuation of
timeshare points. Because of the use of estimates inherent in the financial
reporting process, actual results could differ significantly from those
estimates. Fixed Assets Fixed assets are
stated at cost and consist of computers and other office equipment. Depreciation
is computed using the accelerated double-declining method based on estimated
useful lives of 3 years. Cash and
Cash Equivalents For the purpose of the statements of cash
flows, the Company considers all highly liquid debt instruments purchased with a
maturity of three months or less to be cash equivalents. The Company had $213
and $7,473 in cash at June 30, 2008 and December 31, 2007, respectively.  Advertising The Company generally expenses advertising
costs as incurred. No advertising costs were incurred during the period of
February 25, 2004 (inception) through June 30, 2008.  9    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  1. Organization and Summary of
Significant Accounting Policies (continued) Recently Issued Accounting
Pronouncements In May of 2008, the Financial Accounting Standards Board
(FASB) issued Statement of Financial Accounting Standards (SFAS) No. 163,
Accounting for Financial Guarantee Insurance  an interpretation of FASB
Statement No. 60, Accounting and Reporting by Insurance Enterprises.This statement requires that an insurance enterprise recognize a claim
liability prior to an event of default (insured event) when there is evidence
that credit deterioration has occurred in an insured financial obligation.
 This statement also clarifies how Statement 60 applies to financial
guarantee insurance contracts.  This statement is effective for fiscal
years beginning after December 15, 2008.  This statement has no effect on
the Companys financial reporting at this time.  In May of 2008, the FASB issued SFAS No. 162, The
Hierarchy of Generally Accepted Accounting Principles.This statement
identifies literature established by the FASB as the source for accounting
principles to be applied by entities which prepare financial statements
presented in conformity with generally accepted accounting principles (GAAP) in
the United States.  This statement is effective 60 days following approval
by the SEC of the Public Company Accounting Oversight Board amendments to AU
Section 411, The Meaning of Present Fairly in Conformity With Generally
Accepted Accounting Principles.This statement will require no
changes in the Companys financial reporting practices.  In March 2008, the Financial Accounting
Standards Board (FASB) issued Statement of Financial Accounting Standards
(SFAS) No. 161, Disclosures about Derivative Instruments and Hedging
Activities (an amendment to SFAS No. 133). This statement is effective for
financial statements issued for fiscal years and interim periods beginning after
November 15, 2008 and requires enhanced disclosures with respect to derivative
and hedging activities. The Company will comply with the disclosure requirements
of this statement if it utilizes derivative instruments or engages in hedging
activities upon its effectiveness.  In December 2007, the FASB issued SFAS No.
141 (revised 2007), Business Combinations. This revision to SFAS No.
141 requires an acquirer to recognize the assets acquired, the liabilities
assumed, and any noncontrolling interest in the acquiree at the acquisition
date, at their fair values as of the acquisition date, with limited exceptions.
This revision also requires that acquisition-related costs be recognized
separately from the assets acquired and that expected restructuring costs be
recognized as if they were a liability assumed at the acquisition date and
recognized separately from the business combination. In addition, this revision
requires that if a business combination is achieved in stages, that the
identifiable assets and liabilities, as well as the noncontrolling interest in
the acquiree, be recognized at the full amounts of their fair values. The
Company believes that when and if its development stage activities in seeking a
reverse acquisition of an operating entity occur, this accounting statement may
have relevance.  In December 2007, the FASB issued SFAS No.
160, Noncontrolling Interests in Consolidated Financial Statements, an
amendment of ARB No. 51. The objective of this statement is to improve the
relevance, comparability, and transparency of the financial statements by
establishing accounting and reporting standards for the Noncontrolling interest
in a subsidiary and for the deconsolidation of a subsidiary. The Company
believes that this statement will not have any impact on its financial
statements, unless it becomes an entity requiring consolidation with one or more
corporations.   None of the above new pronouncements has
current application to the Company, but may be applicable to the Companys
future financial reporting.        10    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  1. Organization and Summary of Significant Accounting
Policies (continued)  Revenue Recognition  As described in Note 3, the Company has
acquired an interest in a timeshare property. Revenues were originally intended
to be recognized upon sale of timeshare points redeemable for utilization of the
property, or when the Company performs other travel related services. The
Company has recognized minimal revenue of $4,000 from its initial intended
business purpose since inception through June 30, 2008.  As more fully described in Note 9, the
Company entered into an asset purchase agreement in August 2007 with
Immureboost, Inc. of Thailand, whereby it plans to develop processes, products
and pharmaceuticals that interact with the immune system.  The Company will
reexamine its revenue recognition policy upon completion of the agreement, which
has not yet occurred.  Earnings (Loss) Per Share The computation of net income (loss) per
share of common stock is based on the weighted average number of shares
outstanding during the period presented. There were no potentially dilutive
common share equivalents outstanding during the periods shown and, accordingly,
the computation of net loss per share on a fully dilutive basis is the same as
basic net loss per share.  2.  Related Party
Transactions On April 22, 2004,
the Company entered into a consulting agreement with an entity affiliated with
its former president/director. The entity was engaged to perform consulting
services and provide office space for the Company for a term of six months
commencing April 22, 2004, in exchange for $15,000. On December 30, 2004, the
president/director resigned from his position with the Company. For the period of February 25, 2004
(inception) through April 22, 2004 (see above paragraph), and for the period of
July 2006 to the present (Note 5), office space and services have been provided
without charge by the Company's CEO. Such costs are immaterial to the financial
statements and have not been reflected therein.  In February 2007, the Companys then sole
Officer (the Former Officer) loaned the Company $300 to pay for operating
expenses.  Upon the resignation from his positions with the Company
effective August 28, 2007, the Former Officer forgave the amounts owed to him.
 The Company has written off the debt to additional paid-in capital.  On June 15, 2007, the Company appointed a
new Director to its Board of Directors.  On August 28, 2007, this
individual was appointed as the Companys CEO (the Officer).  In March
2007, prior to these appointments, the Officer advanced the Company a total of
$32,000 pursuant to two promissory notes (Note 7).  The notes are due on
demand and accrue interest at 8% per annum.  No payments have been made on
the notes since its inception, resulting in accrued interest of $2,133 at June
30, 2008.  On July 6, 2007, the Company entered into
an employment agreement with the Officer, whereby the Officer would perform
various services for the Company in exchange for annual Officer compensation of
300,000 Euros, plus 100,000 Euros for annual Director's fees.  The
compensation was translated from Euros into US dollars using a weighted average
exchange rate pro-rated for the period of July 2007 through June 2008, resulting
in $309,043 compensation expense for the six months ended June 30, 2008 and
total accrued compensation of $592,873 at June 30, 2008.  In July 2008,
this Officer resigned from his position, thereby terminating the employment
agreement.  All services under the agreement were performed and
compensation expense pro-rated through the date of the Officers
resignation.   11    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  3.  Intangible
Asset The Company has acquired an undivided
interest in the Wyndham Vacation Resorts (formerly Fairfield Resorts, Inc.)
(WVR) timeshare resort, along with the rights to participate in timeshare use,
or to allow certain others the use, of a specified number of days lodging in WVR
timeshare properties. These rights are granted in the form of points. In June of
2004, the Company purchased 315,000 points from WVR and was given a bonus of
300,000 additional points as an incentive, and will receive 315,000 points on
each anniversary date for the next 99 years.  The points operate as
currency and are redeemable at any time at any WVR resort during the year.
Although the points represent a specific interest in the Grand Desert Resort in
Las Vegas, Nevada, they can be used at any time in exchange for accommodations
at any of the other properties around the world owned by WVR. The contract sales
price of the points was $33,100 and is being financed through WVR (Note 7). As of June 30,
2008, the Company had received a total of 1,560,000 travel points.  On
August 25, 2006, the Company entered into an agreement with a consultant (the
Consultant) whereby the Company transferred 600,000 travel points (valued by
the Consultant at $0.046 per point) to the Consultant to settle debts totaling
$27,576, resulting in a balance of 645,000 points at December 31, 2006.
 During 2007, the Company paid 300,000 points (also valued at $0.046 per
point) pursuant to a consulting agreement (Note 6), resulting in remaining total
available points of 660,000 at December 31, 2007. As explained more
fully in Note 10, the point transfers result in a reduction of the intangible
asset equal to the original cost of the points transferred.  The difference
between the fair market value and the cost of the points is reported as a gain
on disposal of assets in the Other Income (Expense) section of the Statements of
Operations.  The per-point original cost of $0.001 resulted in a reduction
in the intangible asset of $600 and $300 during the years ended December 31,
2007 and 2006, respectively, due to each of the points transfers, resulting in a
carrying value of the intangible asset of $32,200 and $32,500 at December 31,
2007 and 2006 (restated), respectively. The Company recognized a gain on
disposal of assets of $13,488 and $26,976 during the years ended December 31,
2007 and 2006 (restated), respectively.  No point transfers occurred during
the six months ended June 30, 2008 or 2007. In light of the
asset purchase agreement entered into during August 2007 (Note 9), the Company
has decided to focus on its immune boosting business and is currently seeking to
dispose of the intangible asset.  As a result, the carrying value of the
asset was impaired and written down to $0 during the fourth quarter of 2007.
  The impairment was recorded as a separate component of other income
and expenses in the statements of operations.  12    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008 4.  Stockholders' Equity During March and April 2004, the Company issued common
stock for cash in accordance with separate private offering memorandums as
follows: Number of
shares Price
per share Cash received 13,500,000 $ .000067 $ 900 14,250,000 .00067 9,500 15,000,000 .002 30,000 5,700,000 .0033 19,000 2,400,000 .0067 16,000 50,850,000 $ 75,400  The Board of Directors authorized a 30:1
forward stock split on July 1, 2006, and a 2:1 reverse stock split on June 12,
2007.  The number of shares issued in accordance with private offerings in
2004 as listed above have been retroactively restated to include the effects of
the splits.  Pursuant to a Form 8-K filed with the SEC
on July 28, 2006, the Board of Directors voted to increase the Companys
authorized common shares from 75,000,000 to 1,000,000,000 shares.  On October 1, 2006, the Company issued
75,000 shares of common stock at $.0067 per share to its transfer agent for $500
in services, resulting in 50,925,000 common shares issued and outstanding at
June 30, 2008 and December 31, 2007.  5.  Commitments and
Contingencies The Company entered
into a lease agreement for office space in Nevada for a one-year period
commencing April 1, 2005 with monthly rent payments of $400. The Company paid
$4,800 for the entire year of rent up front, an initial security deposit of
$1,200, and $625 for use of the lessors office furniture for the term of the
lease.  The initial security deposit was applied towards rent for the
period of April through June 2006. Rent expense and amortization of the office
furniture fund for the year ended December 31, 2006 was $2,816, resulting in $0
prepaid rent and deposits at December 31, 2006.  The contract was not
renewed upon its expiration, and during the period of July 2006 through the
present, the Companys officers have been providing office space at no cost to
the Company.  6.  Consulting Agreement  In October 2006, the Company entered into
an agreement with an unrelated consultant (the Consultant), who would perform
services for the Company during the fourth quarter of 2006.  As
compensation, the Company was required to pay the Consultant $9,000 cash and
300,000 timeshare points.  The points were valued at $0.046, which is
proportionate to the 600,000 points transferred to another consultant to satisfy
$27,576 in debt owed to that consultant (Note 3).  Accordingly, the 300,000
points were assigned a value of $13,788, resulting in a payable due the
Consultant of $22,788 at December 31, 2006.  The points were transferred to
the Consultant during the year ended December 31, 2007, resulting in a $300
reduction of the original cost of the intangible asset (timeshare investment)
and a gain on disposal of assets of $13,488.  Upon transfer of the points,
the Company failed to record a corresponding reduction in the consulting fees
due the Consultant, and paid additional cash in an attempt to satisfy the
perceived remaining payable, resulting in an overpayment.  Also during
2007, the Consultant forgave debts owed by the Company totaling $3,036.
 The net result of the $13,788 overpayment and $3,036 debt forgiveness
resulted in a net receivable due from the Consultant of $10,752 at December 31,
2007.  During the six months ended June 30, 2008, the Consultant paid
$2,642 of expenses on behalf of the Company reducing the receivable to $8,110 as
of June 30, 2008.  The accounting treatment of the points
transfer is more fully discussed in Notes 3 and 10.  The agreement was not
renewed for a subsequent term.     13    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  7. Notes Payable  Principal balanceJune 30

December 312008

2007Note payable  timeshare:Wyndham Vacation Resorts (Note 3) for $33,100 
June 2004 inception, June 2014 maturity, $415 monthly payments, 10.99%
annual interest, collateralized by the timeshare property with $0 carrying
value at June 30, 2008.  Interest expense of $1,293 and $1,284 for
the six months ended June 30, 2008 and 2007, respectively.

Future maturities due during the year ended
December 31 are as follows:

2008
$
2,570
2009
2,867
2010
3,198
2011
3,568
2012
3,980
Thereafter
6,881
Total
$
               23,064
$
        21,851

$
      23,064,Short-term loansIndependent investor for $22,994  March 2007
inception, September 2007 maturity, 5.25% annual interest plus 1% interest
per month late fee each month after maturity, unsecured.  Interest
expense of $1,983 (including $1,380 late fees) and $0 for the six months
ended June 30, 2008 and 2007.  Accrued interest of $3,506 (including
$2,300 late fees) as of June 30, 2008.
22,994

22,994Independent investor for $15,000  November 2007
inception, due on demand, 8% annual interest, unsecured.  Interest
expense of $600 for the six months ended June 30, 2008.  Accrued
interest of $750 as of June 30, 2008.
15,000

15,000Independent investor for $26,500  April, 2008
inception, due on demand, non-interest bearing, unsecured.
  Interest has not been imputed due to immaterial effect on the
financial statements for the three months ended June 30, 2008.
26,500

-Total short-term
loans
64,494

37,994Related party notes payable:Officer loan for $10,000  August 2007 inception,
due on demand, 8% annual interest, unsecured.  Interest expense of
$400 for the six months ended June 30, 2008.  Accrued interest of
$667 as of June 30, 2008.
10,000

10,000Officer loan for $22,000  August 2007 inception,
due on demand, 8% annual interest, unsecured.  Interest expense of
$880 for the six months ended June 30, 2008.  Accrued interest of
$1,466 as of June 30, 2008.
22,000

22,000Total related
party notes payable
32,000

32,000Total notes payable
118,345

93,058Less current portions and short-term loans
99,135

72,564Total notes payable  long-term
$
      19,210

$
      20,494   14    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  8.  Going Concern and Liquidity
Considerations The accompanying
financial statements have been prepared assuming that the Company will continue
as a going concern, which contemplates, among other things, the realization of
assets and satisfaction of liabilities in the normal course of business.
 As at June 30, 2008, the Company has a working capital deficit of $698,368
and an accumulated deficit of $793,732.  Unanticipated costs and expenses
or the inability to generate revenues could require additional financing, which
would be sought through bank borrowings, equity or debt financing, or asset
sales. To the extent financing is not available, the Company may not be able to,
or may be delayed in, developing its services and meeting its obligations. The Company will
continue to evaluate its projected expenditures relative to its available cash
and to evaluate additional means of financing in order to satisfy its working
capital and other cash requirements. The accompanying financial statements do
not reflect any adjustments that might result from the outcome of these
uncertainties. 9.  Asset Purchase Agreement On August 18, 2007,
the Company entered into an Asset Purchase Agreement with Immureboost, Inc., a
Thai corporation (the "Seller") that develops processes, products and
pharmaceuticals that interact with the immune system. Under the terms of the
Agreement, the Company will acquire certain assets of the Seller, including
patents and trademarks. As consideration for these assets, certain stockholders
of the Seller will receive 20,370,000 restricted shares (as defined in Rule 144
of the Securities Act of 1933) of the Company's common stock, which shall
constitute 40% of the stock issued and outstanding at December 31, 2007, and 29%
of total shares issued and outstanding after the shares are issued.  The
purchase has not yet been completed and no shares have been issued or assets
acquired as a result of the agreement. The Company does
not believe that the Seller will be able to deliver the assets as set forth in
the Agreement, and the Seller may not have rights to patents and trademarks as
represented in the Agreement.  Therefore, the Company is of the opinion the
Seller has breeched the Agreement, and is in the process of enforcing its rights
and obligations thereunder to terminate the agreement. 10.
 Restatement of Prior Year Audited Financial Statements The Company has
restated its June 30, 2007 financial statements, primarily due to improper
accounting for the transfer of its timeshare points acquired from Wyndham
Vacation Resorts (formerly Fairfield Resorts, Inc.) (WVR) for $33,100 in June
2004 (Note 3).  Since the Companys interest in the WVR conglomerate was
deemed to have a nominal value, the entire purchase price was assigned to the
points, recorded in the financial statements as an intangible asset.
 Although the term of the sales contract stated the Company was to receive
additional points annually for 99 years, the Company initially determined that
the points did not have a finite useful life over which to amortize their cost,
so the intangible asset would be tested for impairment in accordance with SFAS
No. 142, "Goodwill and Other Intangible Assets."  The Company noted
no impairment of the intangible during 2004 through 2006, and when points were
transferred to other parties in the two transactions described in Note 3, there
was no corresponding depletion of the asset.  If a sales transaction were
to occur, there would be no way to determine cost of goods sold. The Company
determined to assign the sales contract price ratably to the potential points
the Company is entitled to receive over the life of the contract.  The
Company is entitled to receive 315,000 points for 99 years, plus 300,000 bonus
points granted upon inception, which equates to 31,485,000 potential points over
the contract life, resulting in a per-point value (cost) of $.001. In a revenue-generating transaction, the
intangible asset will be reduced by the cost of the points sold, with an
offsetting entry to cost of sales.  Revenue will be recorded in the amount
of consideration received, resulting in a gross margin of the difference between
the asset cost and fair market value.  When points are transferred to other
parties as repayment for services or debt in lieu of cash, a gain on disposal of
an asset is recorded in the Other Income section of the statements of
operations.  This is not considered a revenue transaction, but rather a
disposal of the intangible asset.   15    IMMUREBOOST,
INC. (formerly ESAVINGSSTORE.COM, Inc.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Six Months Ended June 30,
2008  10.  Restatement of Prior
Year Audited Financial Statements (continued) The restatement relates to the August 2006
transfer of 600,000 points to satisfy debt of $27,576 (Note 3), which was
originally accounted for as $27,576 in revenues.  Application of the
correct accounting treatment results in a reduction of the intangible asset by
the points original cost of $600 at $.001 per point.  The difference
between the points original cost and their fair market value (i.e., the debt
amount) has been recorded as a gain on disposal of assets, resulting as a net
$600 adjustment to the accumulated deficit opening balance.  This
restatement is considered a correction of an error in previously issued
financial statements pursuant to SFAS No. 154, "Accounting Changes and Error
Corrections."    The error has been addressed as a prior
period adjustment in the attached restated June 30, 2007 financial statements,
as demonstrated in the below table.  No change in loss per share was noted
as a result of the restatement.  Original
Restatement
RestatedAccount
Balance
Adjustment
BalanceThree Months Ended June 30,
2007Cash
$
               300
$
                    -
$
               300Equipment
4,222
-
4,222Accumulated depreciation
(4,082)
-
(4,082)Intangible asset
33,100
(600)
32,500Accounts payable
(33,003)
-
(33,003)Note payable - related party
(23,294)
23,294
-Short term note payable
-
(23,294)
(23,294)Current portion of notes payable - timeshare
(2,303)
-
(2,303)Notes payable  timeshare
(21,913)
-
(21,913)Common stock
(50,925)
-
(50,925)Additional paid-in capital
(24,975)
-
(24,975)Deficit accumulated during dev stage
107,636
600
108,236General and administrative expenses
14,631
-
14,631Interest expense
606
-
606Total
$
                   -
$
                  -
$
                    -  Six Months Ended June 30,
2007Cash
$
               300
$
                    -
$
               300Equipment
4,222
-
4,222Accumulated depreciation
(4,082)

(4,082)Intangible asset
33,100
(600)
32,500Accounts payable
(33,003)
-
(33,003)Note payable - related party
(23,294)
23,294
-Short term note payable
-
(23,294)
(23,294)Current portion of notes payable - timeshare
(2,303)
-
(2,303)Notes payable  timeshare
(21,913)
-
(21,913)Common stock
(50,925)
-
(50,925)Additional paid-in capital
(24,975)
-
(24,975)Deficit accumulated during dev stage
99,549
600
100,149General and administrative expenses
22,040
-
22,040Interest expense
1,284
-
1,284Total
$
                   -
$
                  -
$
                    -  16     Item 2.  Managements Discussion and Analysis of
Financial Condition and Results of Operations. Immureboost, Inc. was
incorporated in the State of Nevada on February 25, 2004.  Since its
inception, the Company has not been involved in any bankruptcy, receivership or
similar proceedings.  It has not undergone any material reclassification,
merger, consolidation, or purchase or sale of a significant amount of assets in
the ordinary course of business.  GENERAL  Prior to August 18,
2007, the Company was in the business of providing travel bookings and timeshare
rentals and sales. Immureboost, Inc. was formed on February 25, 2004 under the
name Celtic Cross, Inc. as a For Profit corporation for the purpose of
acquiring the timeshare entities discussed herein, and additional like entities
going forward including a full sales and service website.  The Company has
elected a fiscal year end of December 31.  On July 17, 2006, the
Board of Directors voted to change the name of the Company to eSavingStore.com,
Inc. to more accurately reflect the Companys business plan.  On July 5,
2007, the stockholders of the Company approved the name change to Immureboost,
Inc.  On August 18, 2007, the Company entered into an Asset Purchase
Agreement (Agreement) with Immureboost of Thailand, a Thai corporation (the
"Seller") which develops processes, products, and pharmaceuticals that interact
with the immune system. Under the terms of the Agreement, the Company would have
acquired certain assets of the Seller, including patents and trademarks. In
consideration of these assets, certain stockholders of the Seller would have
received twenty million three hundred seventy thousand (20,370,000) "restricted
shares" (as that term is defined in Rule 144 of the Securities Act of 1933; the
"Act") of the Company's Common Stock.  At June 30, 2008, the Seller
was still in the process of transferring the intellectual property rights to the
Company.  As of the date of
this report, the Company does not believe that the Seller will be able to
deliver the assets as set forth in the Agreement, and the Seller may not have
rights to patents and trademarks as represented in the Agreement.
 Therefore, the Company is of the opinion the Seller has breeched the
Agreement, and is in the process of enforcing the Companys termination rights
thereunder.  No shares were issued pursuant to the Agreement.  The Company is
currently seeking new projects in the field of products that beneficially
interact with the immune system. The
Company still owns an undivided interest in the Wyndham Vacation Resorts
(formerly Fairfield Resorts, Inc.) (WVR) timeshare resort, along with the
rights to participate in timeshare use, or to allow certain others the use, of a
specified number of days lodging in WVR timeshare properties. In
June of 2004, the Company purchased 315,000 points from WVR and was given a
bonus of 300,000 additional points as an incentive. The Company receives 315,000
points on each anniversary date in October for the next 99 years and had
accumulated 660,000 total available points at June 30, 2008. The maintenance at
the WVR facilities are the responsibility of WVR, however, the Company pays a
monthly fee to WVR for this service. The maintenance fee is $141 per month at
our current ownership level. The points are redeemable at numerous resort
locations around the world. These points can be used to rent vacation or
business use accommodations. The "points" represent a specific interest in the  17    Grand
Desert Resort in Las Vegas, NV, and can be used in exchange for accommodations
at any of the other properties around the world owned by WVR.  The Company
is in the process of attempting to sell this interest and relieve itself of the
quarterly payments.  RESULTS OF
OPERATIONS The Company has
generated $4,000 in revenues since inception, and has an accumulated deficit of
$793,732.  During the six months ended June 30, 2008 and 2007, we incurred
$339,335 and $1,284 in operating expenses.  At June 30, 2008, we had total
current assets of $8,323 and current liabilities of $706,691, resulting in a
working capital deficit of $698,368.  LIQUIDITY. During
the next 12 months, the Company will need significant working capital to fund
the research efforts. The Company intends to obtain working capital either from
the sale of product or through private investments made by third parties or debt
instruments.  Item
3. Quantitative
and Qualitative Disclosures About Market Risk  Not
Required  Item
4T. Controls
and Procedures  Evaluation
of Disclosure Controls and Procedures  Evaluation of
Disclosure Controls and Procedures  Under the supervision
and with the participation of our management, including our principal executive
officer and principal financial officer (or persons performing those duties), we
have conducted an evaluation of the effectiveness of the design and operation of
our disclosure controls and procedures, as defined in Rules 13a-15(e) and
15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the
period covered by this report.  Based on this evaluation, our principal
executive officer and principal financial officer, or persons performing those
duties, concluded as of the evaluation date that our disclosure controls and
procedures were effective such that the material information required to be
included in our Securities and Exchange Commission reports is recorded,
processed, summarized and reported within the time periods specified in SEC
rules and forms relating to our company, particularly during the period when
this report was being prepared.  Additionally, there
were no significant changes in our internal controls or in other factors that
could significantly affect these controls subsequent to the evaluation date.
 We have not identified any significant deficiencies or material weaknesses
in our internal controls, and therefore there were no corrective actions
taken. PART
II - OTHER INFORMATION  Item
1. Legal
Proceedings.  None  Item 1A. Risk
Factors  18     Not applicable  Item
2. Unregistered
Sales of Equity Securities and Use of Proceeds.  None.  Item
3. Defaults
Upon Senior Securities.  None  Item
4. Submission
of Matters to a Vote of Security Holders.  None.  Item
5. Other
Information.  None.  Item
6. Exhibits.  The
following exhibits are filed herewith: 31.1
Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act of 1934, as amended. 32.1
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.          19    SIGNATURES Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly
authorized. IMMUREBOOST,
INC. Name

Title

Date/s/
Tony Jimenez

CEO, CFO, Director

8/19/2008   20